Over one third of survey respondents living with lupus were unable to access the COVID-19 vaccine earlier than the general population
The World Lupus Federation (WLF) is working with lupus organizations around the globe to conduct a survey focusing on the impact of the COVID-19 pandemic on individuals with lupus.
The Addressing Lupus Pillars for Health Advancement (ALPHA) project is a unique global consensus initiative that seeks to identify and prioritize the fundamental barriers or knowledge gaps that will allow providers, researchers and scientists to improve diagnosis, treatment and systems of care for people with lupus.
The World Lupus Federation conducted a global survey on how lupus affects physical function and quality of life.
World Lupus Federation survey data finds that lupus affects mobility and ability to conduct normal activities.
GSK conceived, developed and led the ‘A Vision for Lupus’ initiative in collaboration with a Global Multidisciplinary Steering Committee, and the report outlines three specific, patient-centred Calls to Action to the lupus community.
The health effects of lupus can have a substantial impact on the lives of people with lupus and their families and caregivers.
In a survey conducted by the Lupus Foundation of America, it was revealed that, on average, people with lupus live with symptoms six years before they are about to obtain a lupus diagnosis.
The Word Lupus Federation will undertake initiatives to bring a greater understanding of the disease among the public and also among the medical community and government policymakers.
A new study concludes that hydroxychloroquine therapy is safe for long-term use at doses <5 mg/kg/day.